150 related articles for article (PubMed ID: 35152841)
1.
Zheng Y; Su L; Tan J; Dong F
Bioengineered; 2022 Mar; 13(3):4911-4922. PubMed ID: 35152841
[TBL] [Abstract][Full Text] [Related]
2. Actinidia Chinensis Planch Root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting the DLX2/TARBP2/JNK/AKT pathway.
Fang T; Zhao Z; Yuan F; He M; Sun J; Guo M; Huang P; Yang B; Xia J
J Ethnopharmacol; 2020 Apr; 251():112529. PubMed ID: 31891797
[TBL] [Abstract][Full Text] [Related]
3. Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition.
Fang T; Fang Y; Xu X; He M; Zhao Z; Huang P; Yuan F; Guo M; Yang B; Xia J
J Ethnopharmacol; 2019 Mar; 231():474-485. PubMed ID: 30415058
[TBL] [Abstract][Full Text] [Related]
4. Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression.
Fang T; Hou J; He M; Wang L; Zheng M; Wang X; Xia J
Cell Biol Toxicol; 2016 Dec; 32(6):499-511. PubMed ID: 27475644
[TBL] [Abstract][Full Text] [Related]
5. Actinidia chinensis Planch root extract inhibits cholesterol metabolism in hepatocellular carcinoma through upregulation of PCSK9.
He M; Hou J; Wang L; Zheng M; Fang T; Wang X; Xia J
Oncotarget; 2017 Jun; 8(26):42136-42148. PubMed ID: 28178673
[TBL] [Abstract][Full Text] [Related]
6. Actinidia chinensis Planch. root extract inhibits the proliferation, migration and invasion of breast cancer cells via the AKT/GSK-3β signaling pathway.
Gan C; Jin Z; Wei X; Jin M
Folia Histochem Cytobiol; 2021; 59(4):226-235. PubMed ID: 34852177
[TBL] [Abstract][Full Text] [Related]
7. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.
Ye Y; Gu B; Wang Y; Shen S; Huang W
J Cell Biochem; 2019 Apr; 120(4):6145-6153. PubMed ID: 30362161
[TBL] [Abstract][Full Text] [Related]
8. Regulatory roles of OASL in lung cancer cell sensitivity to Actinidia chinensis Planch root extract (acRoots).
Lv J; Wang L; Shen H; Wang X
Cell Biol Toxicol; 2018 Jun; 34(3):207-218. PubMed ID: 29508110
[TBL] [Abstract][Full Text] [Related]
9. MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer.
Zhu Q; Zhang C; Qu T; Lu X; He X; Li W; Yin D; Han L; Guo R; Zhang E
Cancer Res; 2022 Dec; 82(23):4340-4358. PubMed ID: 36214649
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
Shen Y; Lv M; Fang Y; Lu J; Wu Y
J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
[TBL] [Abstract][Full Text] [Related]
12. Exploring the anticancer potential of Actinidia chinensis Planch root extracts (
Qiu K; Xia Q; Chen H; Ye Q; Mao H; Tian M; Gan Y; Huang Q; Wang H; Duan S
Heliyon; 2023 Nov; 9(11):e21851. PubMed ID: 38027882
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D; Wang Y; Sun B; Yang J; Luo X
Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
Lv Y; Li H; Li F; Liu P; Zhao X
Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
[TBL] [Abstract][Full Text] [Related]
15. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer.
Li Z; Wang F; Zhang S
FEBS Open Bio; 2019 May; 9(5):851-858. PubMed ID: 30980513
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
[TBL] [Abstract][Full Text] [Related]
18. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.
Liu S; Li H; Zhu Y; Ma X; Shao Z; Yang Z; Cai C; Wu Z; Li M; Gong W; Wu X
Cancer Lett; 2022 Oct; 547():215862. PubMed ID: 35953000
[TBL] [Abstract][Full Text] [Related]
20. Activation of MYO1G by lncRNA MNX1-AS1 Drives the Progression in Lung Cancer.
Lv D; Wang Y; Li S; Shao X; Jin Q
Mol Biotechnol; 2023 Jan; 65(1):72-83. PubMed ID: 35819746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]